Transcriptomic analysis reveals new hippocampal gene networks induced by prolactin.
Animals
Female
Gene Expression Profiling
/ methods
Gene Regulatory Networks
/ drug effects
Hippocampus
/ drug effects
Lactation
/ drug effects
Microglia
/ drug effects
Neurogenesis
/ drug effects
Neurons
/ drug effects
Neuroprotection
/ drug effects
Neuroprotective Agents
/ pharmacology
Prolactin
/ pharmacology
Rats
Rats, Wistar
Transcriptome
/ drug effects
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 09 2019
24 09 2019
Historique:
received:
03
01
2019
accepted:
02
09
2019
entrez:
26
9
2019
pubmed:
26
9
2019
medline:
30
10
2020
Statut:
epublish
Résumé
Prolactin (Prl) is a pleiotropic hormone with multiple functions in several tissues and organs, including the brain. In the hippocampus, Prl has been implicated in several functions, including neuroprotection against excitotoxicity in lactating rats and in Prl-treated ovariectomized animals. However, the molecular mechanisms involved in Prl actions in the hippocampus have not been completely elucidated. The aim of this study was to analyse the hippocampal transcriptome of female Prl-treated ovariectomized rats. Transcriptomic analysis by RNASeq revealed 162 differentially expressed genes throughout 24 h of Prl treatment. Gene Ontology analysis of those genes showed that 37.65% were involved in brain processes that are regulated by the hippocampus, such as learning, memory and behaviour, as well as new processes that we did not foresee, such as glial differentiation, axogenesis, synaptic transmission, postsynaptic potential, and neuronal and glial migration. Immunodetection analysis demonstrated that Prl significantly modified microglial morphology, reduced the expression of Cd11b/c protein, and altered the content and location of the neuronal proteins Tau, Map2 and Syp, which are involved in axogenic and synaptic functions. This novel delineation of Prl activity in the hippocampus highlights its importance as a neuroactive hormone, opens a new avenue for understanding its actions and supports its participation in neuronal plasticity of this brain area.
Identifiants
pubmed: 31551509
doi: 10.1038/s41598-019-50228-7
pii: 10.1038/s41598-019-50228-7
pmc: PMC6760160
doi:
Substances chimiques
Neuroprotective Agents
0
Prolactin
9002-62-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13765Références
Front Aging Neurosci. 2017 Jun 16;9:191
pubmed: 28670274
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Horm Behav. 2006 Feb;49(2):131-42
pubmed: 16005000
J Neuroendocrinol. 2008 Jun;20(6):752-63
pubmed: 18601698
Neurobiol Aging. 2017 Dec;60:92-103
pubmed: 28941407
Neuroscience. 2013 Dec 3;253:132-41
pubmed: 23994182
Neuron. 2012 Nov 8;76(3):549-64
pubmed: 23141067
Brain Res. 2016 Apr 1;1636:193-199
pubmed: 26874070
Nature. 1999 Nov 11;402(6758):137-8
pubmed: 10647003
Dev Cell. 2016 Jul 25;38(2):126-8
pubmed: 27459063
J Comp Neurol. 1990 Jan 8;291(2):269-80
pubmed: 1967618
J Neuroendocrinol. 2013 Jun;25(6):519-27
pubmed: 23356710
Nat Rev Neurosci. 2015 Jun;16(6):358-72
pubmed: 25991443
Neuron. 2011 Aug 11;71(3):433-46
pubmed: 21835341
Behav Neurosci. 2005 Aug;119(4):1084-96
pubmed: 16187836
BMC Psychiatry. 2018 Aug 1;18(1):246
pubmed: 30068291
Int Neurourol J. 2016 May;20(Suppl 1):S2-7
pubmed: 27230456
Neuroscience. 2013 Sep 17;248:552-61
pubmed: 23830906
Neurosci Lett. 2019 Feb 16;694:116-123
pubmed: 30500398
Brain Behav Immun. 2012 Feb;26(2):201-9
pubmed: 21820505
Endocrinology. 1995 Jun;136(6):2442-50
pubmed: 7750466
Am J Physiol Endocrinol Metab. 2013 Nov 1;305(9):E1154-64
pubmed: 24022869
Neurosci Lett. 2006 Feb 27;395(1):87-92
pubmed: 16300887
Annu Rev Neurosci. 2012;35:369-89
pubmed: 22715882
Horm Behav. 2008 Jan;53(1):112-23
pubmed: 17963758
Science. 2003 Jan 3;299(5603):117-20
pubmed: 12511652
J Cereb Blood Flow Metab. 2015 Nov;35(11):1804-11
pubmed: 26104289
J Neurobiol. 2006 Jan;66(1):71-81
pubmed: 16216005
Endocr Rev. 1998 Jun;19(3):225-68
pubmed: 9626554
Genome Biol. 2003;4(5):P3
pubmed: 12734009
Physiol Behav. 1993 Jul;54(1):151-4
pubmed: 8327594
Mol Endocrinol. 2014 May;28(5):622-33
pubmed: 24694306
J Toxicol Sci. 2015 Aug;40(4):437-50
pubmed: 26165640
Nat Neurosci. 2010 Jun;13(6):753-8
pubmed: 20453850
PLoS One. 2017 May 5;12(5):e0176910
pubmed: 28475602
Mol Cell Endocrinol. 2004 May 31;220(1-2):41-50
pubmed: 15196698
Mol Psychiatry. 2020 Aug;25(8):1876-1900
pubmed: 29950682
Neurosci Lett. 2009 Sep 18;461(2):136-9
pubmed: 19539698
Biol Psychiatry. 2015 Mar 15;77(6):513-25
pubmed: 24742619
Peptides. 1994;15(5):783-90
pubmed: 7984495
Cell. 2007 Dec 14;131(6):1164-78
pubmed: 18083105
Cell Rep. 2014 Sep 11;8(5):1271-9
pubmed: 25159150
Neuroscience. 2010 Sep 1;169(3):1178-85
pubmed: 20570717
Neuroendocrinology. 2013;98(3):171-9
pubmed: 23969780
Horm Behav. 2006 Feb;49(2):143-9
pubmed: 15992800
Schizophr Res. 2017 Nov;189:117-125
pubmed: 28755878
Neuroscience. 2007 Mar 30;145(3):963-73
pubmed: 17317019
J Neurosci. 2005 Nov 2;25(44):10282-9
pubmed: 16267236
Neuroscience. 2007 Oct 12;149(1):53-67
pubmed: 17869008
Rev Psiquiatr Salud Ment. 2016 Jul-Sep;9(3):158-73
pubmed: 26927534
J Alzheimers Dis. 2013;33(4):1177-90
pubmed: 23168450
Neurosci Lett. 1995 Nov 24;200(3):179-82
pubmed: 9064606
Channels (Austin). 2014;8(3):193-202
pubmed: 24758841
Dev Neurobiol. 2018 Jun;78(6):593-603
pubmed: 29271125
Endocrine. 2017 Aug;57(2):199-213
pubmed: 28634745
Mol Cell Endocrinol. 2008 Dec 16;296(1-2):41-52
pubmed: 18951951
Neuron. 2004 Sep 30;44(1):109-20
pubmed: 15450164
Biochem Biophys Rep. 2017 Sep 05;12:120-128
pubmed: 28955800
Neuroscience. 2019 May 1;405:103-117
pubmed: 29753862
Endocrinology. 2017 Jan 1;158(1):69-83
pubmed: 27805868
Neuron. 2012 May 24;74(4):691-705
pubmed: 22632727
Cereb Cortex. 2016 Mar;26(3):977-90
pubmed: 25405940
PLoS One. 2012;7(9):e44371
pubmed: 22973440